Hippocampal functional imaging-derived radiomics features for diagnosing cognitively impaired patients with Parkinson's disease

被引:0
|
作者
Zeng, Wei [1 ,2 ]
Liang, Xiao [1 ,2 ]
Guo, Jiali [3 ]
Cheng, Weiling [1 ,2 ]
Yin, Zhibiao [3 ]
Hong, Daojun [3 ]
Li, Fangjun [3 ]
Zhou, Fuqing [1 ,2 ]
Fang, Xin [3 ]
机构
[1] Nanchang Univ, Dept Radiol, Jiangxi Prov Key Lab Precis Pathol & Intelligent D, Jiangxi Med Coll,Affiliated Hosp 1, 17 Yongwaizheng St, Nanchang 330006, Peoples R China
[2] Jiangxi Prov Med Imaging Res Inst, Neuroradiol Lab, Nanchang 330006, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 1, Jiangxi Med Coll, Dept Neurol, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China
来源
BMC NEUROSCIENCE | 2025年 / 26卷 / 01期
基金
中国国家自然科学基金;
关键词
Parkinson's disease; Cognitively impaired; Hippocampus; Radiomics; Resting-state functional magnetic imaging; NONMOTOR SYMPTOMS; CONNECTIVITY; ASSOCIATIONS; MRI;
D O I
10.1186/s12868-025-00938-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose The aim of this retrospective study was to investigate whether radiomics features derived from hippocampal functional imaging can effectively differentiate cognitively impaired patients from cognitively preserved patients with Parkinson's disease (PD). Methods The study included a total of 89 clinically definite PD patients, comprising 55 who werecognitively impaired and 34 who were cognitively preserved. All participants underwent functional magnetic resonance imaging and clinical assessments. Preprocessed functional data were utilized to derive the amplitude of the low-frequency fluctuations (ALFF), regional homogeneity (ReHo), voxel-mirrored homotopic connectivity (VMHC), and degree centrality (DC). A standardized set of radiomics features was subsequently extracted from the bilateral hippocampi, resulting in a total of 819 features. Following feature selection, the radiomics score (rad-score) and logistic regression (LR) models were trained. Additionally, the Shapley additive explanations (SHAP) algorithm was employed to elucidate and interpret the predictions made by the LR models. Finally, the relationships between the radiomics features derived from hippocampal functional imaging and the scores of the clinical measures were explored to assess their clinical significance. Results The rad-score and LR algorithm models constructed using a combination of wavelet features extracted from ReHo and VMHC data exhibited superior classification efficiency. These models demonstrated exceptional accuracy, sensitivity, and specificity in distinguishing cognitively impaired PD patients (CI-PD) from cognitively preserved PD (CP-PD) patients, with values of 0.889, 0.900, and 0.882, respectively. Furthermore, SHAP values indicated that wavelet features derived from ReHo and VMHC were critical for classifying CI-PD patients. Importantly, our findings revealed significant associations between radiomics wavelet features and scores on the Hamilton Anxiety Scale, Non-Motor Symptom Scale, and Montreal Cognitive Assessment in CI-PD patients (P < 0.05, with Bonferroni correction). Conclusions Our novel rad-score model and LR model, which utilize radiomics features derived from hippocampal functional imaging, have demonstrated their value in diagnosing CI-PDpatients. These models can enhance the accuracy and efficiency of functional MRI diagnosis, suggesting potential clinical applications.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] To rise and to fall: functional connectivity in cognitively normal and cognitively impaired patients with Parkinson's disease
    Gorges, Martin
    Mueller, Hans-Peter
    Lule, Dorothee
    Pinkhardt, Elmar H.
    Ludolph, Albert C.
    Kassubek, Jan
    NEUROBIOLOGY OF AGING, 2015, 36 (04) : 1727 - 1735
  • [2] Cortical atrophy in cognitively impaired Parkinson's disease patients
    Almuqbel, M. M.
    Melzer, T. R.
    Myall, D. J.
    MacAskill, M. R.
    Livingston, L.
    Wood, K.
    Pitcher, T. L.
    Keenan, R. J.
    Dalrymple-Alford, J. C.
    Andrson, T. J.
    MOVEMENT DISORDERS, 2016, 31 : S397 - S397
  • [3] Clinical EEG in cognitively impaired patients with Parkinson's Disease
    Schlede, Nina
    Zimmermann, Ronan
    Ehrensperger, Michael M.
    Gschwandtner, Ute
    Hardmeier, Martin
    Hatz, Florian
    Monsch, Andreas U.
    Naegelin, Yvonne
    Fuhr, Peter
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 75 - 78
  • [4] Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
    Rektorova, Irena
    Biundo, Roberta
    Marecek, Radek
    Weis, Luca
    Aarsland, Dag
    Antonini, Angelo
    PLOS ONE, 2014, 9 (01):
  • [5] Altered metabolic and functional resting state activity in cognitively unimpaired and impaired Parkinson's disease patients
    Ruppert, M.
    Greuel, A.
    Tahmasian, M.
    Steidel, K.
    Maier, F.
    Hammes, J.
    van Eimeren, T.
    Timmermann, L.
    Tittgemeyer, M.
    Drzezga, A.
    Eggers, C.
    MOVEMENT DISORDERS, 2020, 35 : S270 - S271
  • [6] Decisional capacity in cognitively impaired patients with Parkinson disease
    Marson, Daniel C.
    Hershey, Linda A.
    NEUROLOGY, 2013, 81 (09) : 780 - 781
  • [7] Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease
    Dymek, MP
    Atchison, P
    Harrell, L
    Marson, DC
    NEUROLOGY, 2001, 56 (01) : 17 - 24
  • [8] Feature engineering-based analysis of DaTSCAN-SPECT imaging-derived features in the detection of SWEDD and Parkinson's disease
    Aggarwal, Nikita
    Saini, Barjinder Singh
    Gupta, Savita
    COMPUTERS & ELECTRICAL ENGINEERING, 2024, 117
  • [9] Grey matter atrophy in cognitively impaired Parkinson's disease
    Melzer, Tracy R.
    Watts, Richard
    MacAskill, Michael R.
    Pitcher, Toni L.
    Livingston, Leslie
    Keenan, Ross J.
    Dalrymple-Alford, John C.
    Anderson, Tim J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (02): : 188 - 194
  • [10] Efficacy of pallidotomy and thalamotomy in cognitively impaired Parkinson disease patients
    Wheelock, VL
    King, DS
    Levine, DK
    Duke, CM
    Yu, JT
    Na-Lee, CK
    Pappas, CTE
    Sigvardt, KA
    NEUROLOGY, 2001, 56 (08) : A277 - A278